Inventor · Blue Bell, PA, US

Bryan Wayne King

16Patents
4h-index
65Co-inventors
63Inventor score

Filing activity: Mar 16, 2001 → Feb 26, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6495565B2 &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; Chemistry; Metallurgy 31 Expired
US9556152B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 25 Active
US6927216B2 Cyclic sulfonyl compounds as inhibitors of metalloproteases Chemistry; Metallurgy 15 Expired
US7074810B2 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme Chemistry; Metallurgy 4 Expired
US10940154B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 2 Active
US10590085B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 2 Active
US10292987B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 1 Active
US10933070B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 1 Active
US10899716B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 1 Active
US11485710B2 Heterocyclic amides as kinase inhibitors Chemistry; Metallurgy 0 Active
US10975056B2 Substituted pyridines as inhibitors of DNMT1 Chemistry; Metallurgy 0 Active
US12285436B2 Substituted pyridines as DNMT1 inhibitors Chemistry; Metallurgy 0 Active
US11771711B2 Substituted pyridines as DNMT1 inhibitors Chemistry; Metallurgy 0 Active
US12247033B2 Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors Chemistry; Metallurgy 0 Active
US11377440B2 Modulators of stimulator of interferon genes (STING) Chemistry; Metallurgy 0 Active
US7122560B2 Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.